razoxane has been researched along with Brain Neoplasms in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (14.29) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hasinoff, BB; Hofland, KF; Jensen, PB; Langer, SW; Schroeder, PE; Sehested, M | 2 |
| Boehler, F; Eiter, H; Rhomberg, W; Saely, C; Strohal, R | 1 |
| Holm, B; Jensen, PB; Sehested, M | 2 |
| Jensen, PB; Sehested, M | 1 |
| Marchant, J | 1 |
1 review(s) available for razoxane and Brain Neoplasms
| Article | Year |
|---|---|
DNA topoisomerase II rescue by catalytic inhibitors: a new strategy to improve the antitumor selectivity of etoposide.
Topics: Animals; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Etoposide; Humans; Mice; Razoxane; Topoisomerase II Inhibitors | 1997 |
1 trial(s) available for razoxane and Brain Neoplasms
| Article | Year |
|---|---|
Pharmacokinetics of etoposide in cancer patients treated with high-dose etoposide and with dexrazoxane (ICRF-187) as a rescue agent.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Brain Neoplasms; Carcinoma, Small Cell; Catheters, Indwelling; Chromatography, High Pressure Liquid; Etoposide; Humans; Infusions, Intravenous; Lung Neoplasms; Razoxane | 2004 |
5 other study(ies) available for razoxane and Brain Neoplasms
| Article | Year |
|---|---|
Metabolism of dexrazoxane (ICRF-187) used as a rescue agent in cancer patients treated with high-dose etoposide.
Topics: Aged; Antineoplastic Agents, Phytogenic; Brain Neoplasms; Carcinoma, Non-Small-Cell Lung; Chemotherapy, Adjuvant; Ethylenediamines; Etoposide; Female; Glycine; Half-Life; Humans; Infusions, Intravenous; Lung Neoplasms; Male; Middle Aged; Razoxane | 2003 |
Combined razoxane and radiotherapy for melanoma brain metastases. a retrospective analysis.
Topics: Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Combined Modality Therapy; Disease-Free Survival; Female; Humans; Male; Melanoma; Middle Aged; Radiotherapy; Razoxane; Retrospective Studies; Treatment Outcome | 2005 |
ICRF-187 rescue in etoposide treatment in vivo. A model targeting high-dose topoisomerase II poisons to CNS tumors.
Topics: Amsacrine; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Blood-Brain Barrier; Brain Neoplasms; Carcinoma, Ehrlich Tumor; Central Nervous System Neoplasms; DNA Topoisomerases, Type II; Etoposide; Female; Injections, Intraperitoneal; Lethal Dose 50; Leukemia L1210; Male; Mice; Mice, Inbred DBA; Paclitaxel; Razoxane; Structure-Activity Relationship | 1996 |
Improved targeting of brain tumors using dexrazoxane rescue of topoisomerase II combined with supralethal doses of etoposide and teniposide.
Topics: Amsacrine; Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Drug Administration Schedule; Etoposide; Female; Mice; Mice, Inbred Strains; Razoxane; Survival Rate; Teniposide; Topoisomerase II Inhibitors | 1998 |
Prophylactic chemotherapy following breast cancer: a personal experience.
Topics: Adenocarcinoma; Adenocarcinoma, Scirrhous; Antineoplastic Agents; Brain Neoplasms; Breast Neoplasms; Female; Humans; Levodopa; Neoplasm Metastasis; Razoxane; Tamoxifen | 1977 |